Pharmactive Biotech Products in Europe
Europe: Pharmactive Biotech Products releases ingredient for weight management Pharmactive Biotech Products launches CSAT+, a bioactive blend of carob bean extracts with a synergetic effect. Two animal studies, one published in April 2020, have demonstrated positive metabolic effects from supplementation with the novel, patent-pending carob fruit ingredient. Metabolic Syndrome (MetS), sometimes called Syndrome X, Insulin Resistance, or pre-diabetes, is a group of interrelated conditions that include imbalances in blood sugar, insulin, and blood pressure and accompanies high triglycerides, low HDL cholesterol, and obesity. It often leads to a cluster of disease states, including type 2 diabetes, liver disease, angina, cardiovascular disease, and other cardiometabolic disorders. Carob (Ceratonia siliqua L.) is an ancient pod fruit grown throughout the Mediterranean. It is rich in soluble fibers, such as galactomannan, fructooligosaccharides (FOS), as well as antioxidant compounds known a